Riskpilot← Back to searchSign inGet full accessMIDTBYEN ØYEKLINIKK AS
ASActiveOrg 997826086Olav Tryggvasons Gate 24, 7011 TrondheimMedical specialists activities · NACE 8622Est. 20128 employees
Revenue 2025
NOK 8,8M
-15% vs 2024
EBITDA margin
39.3%
-24% vs 2024
Equity ratio
36.6%
Financial strength
Net profit 2025
NOK 2,3M
-28% vs 2024
| Revenue | NOK 8,8M | -15% |
| EBITDA | NOK 3,4M | -24% |
| Net profit | NOK 2,3M | -28% |
| Total assets | NOK 5,7M | -15% |
| Equity | NOK 2,1M | +1% |
| Employees | 8 | — |
Legal name
MIDTBYEN ØYEKLINIKK AS
Org number
997826086
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
12. januar 2012
Share capital
NOK 30 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Øyelegvirksomhet og annen virksomhet som har naturlig tilknytning til denne.
Address
Olav Tryggvasons Gate 24, 7011 Trondheim
Phone
+4773512824
Email
kontor@midtbyenoyeklinikk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 8 176 | 8 844 | 9 636 | 10 300 | 8 771 |
| Staff expenses | −2 968 | −3 339 | −3 365 | −3 576 | −3 221 |
| EBITDA | 3 315 | 3 593 | 4 309 | 4 565 | 3 448 |
| Depreciation & amort. | −736 | −627 | −504 | −474 | −527 |
| EBIT | 2 579 | 2 966 | 3 805 | 4 091 | 2 920 |
| Net financials | 2 | 8 | 38 | 47 | 50 |
| Profit before tax | 2 581 | 2 974 | 3 843 | 4 137 | 2 971 |
| Tax | 570 | 655 | 846 | 912 | 654 |
| Net profit | 2 011 | 2 319 | 2 997 | 3 225 | 2 317 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 823 | 5 227 | 6 460 | 6 677 | 5 689 |
| Equity | 1 526 | 1 846 | 1 843 | 2 068 | 2 085 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 296 | 3 381 | 4 617 | 4 609 | 3 604 |
| Total debt | 3 296 | 3 381 | 4 617 | 4 609 | 3 604 |
EBITDA margin
39.3%
This company
15.8%
Market median
+149% vs market
20212025
Equity ratio
36.6%
This company
38.2%
Market median
+4% vs market
20212025
Return on equity
111.1%
This company
18.4%
Market median
+504% vs market
20212025
Net profit margin
26.4%
This company
8.1%
Market median
+226% vs market
20212025
Asset turnover
1.54×
This company
1.12×
Market median
+37% vs market
20212025
Debt / equity
1.73×
This company
0.62×
Market median
-179% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RB Chief Executive Officer | Chief Executive Officer | 2012 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Former (2) | ||
| Board of Directors | 2023 – 2024 | |
| Chairman | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MIDTBYEN ØYEKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rønnaug Brandser | Chief Executive Officer | 0 companies |
| Henrik Brandser Olsson | Board of Directors | 0 companies |
| Erland Brandser Olsson | Board of Directors | 0 companies |
| Einar Brandser Olsson | Board of Directors | 0 companies |
| Nils Olof Emanuel Olsson | Chairman | 0 companies |
| Ragnar Haugan | Chairman | 0 companies |